Tumor specific delivery and radiation-enhanced tumor penetration of mesoporous silica nanoparticles for effective radionuclide therapy of ovarian peritoneal metastasis.

Autor: Hargrove D; Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT, USA., Ranjbar S; Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT, USA., Darji M; Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT, USA., Nam S; Rhode Island Nuclear Science Center, RI, USA., Dawson RJ; J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Orlando, FL, USA., Katugampola S; Department of Radiology, Rutgers New Jersey Medical School, NJ, USA., Lin X; Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT, USA., Brown A; Hartford Healthcare Medical Group, Hartford, CT, USA., Carrasco-Rojas N; J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Orlando, FL, USA., Goodwin C; Rhode Island Nuclear Science Center, RI, USA., Howell RW; Department of Radiology, Rutgers New Jersey Medical School, NJ, USA., Bolch WE; J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Orlando, FL, USA., Jay M; Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA; Nami Therapeutics Corporation. Storrs, CT, USA., Salner A; Hartford Healthcare Medical Group, Hartford, CT, USA., Lu X; Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT, USA. Electronic address: xiuling.lu@uconn.edu.

Publikováno v: International journal of pharmaceutics [Int J Pharm] 2024 Dec 09, pp. 125071. Date of Electronic Publication: 2024 Dec 09.